Antimicrobial Activities of Synthetic Arylidine Nicotinic and Isonicotinic Hydrazones

Muhammad Qasim Hayat(National University of Technology), Muhammad Taha(Islamia University of Bahawalpur), Taimoor Baig(University of Karachi), Momin Khan(Abdul Wali Khan University Mardan), Aqeel Ahmad, Khalid Mohammed Khan(Pakistan Agricultural Research Council), Uzma Salar(University of Karachi), Shahnaz Parveen(Central Institute of Medicinal and Aromatic Plants), Sumayya Saeed(University of Karachi)
Letters in Drug Design & Discovery
September 21, 2017
10.2174/1570180814666170914120337
Cited by 11

Related Papers

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
|The Lancet|2024|4.4k
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
|The Lancet|2024|931
Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
|The Lancet|2025|801
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|674
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
|The Lancet Haematology|2023|541